PBAC decisions
—
unique drugs assessed
Recommended
—
of all PBAC outcomes
Avg. submissions to listing
—
across recommended drugs
PBS benefit (latest year)
—
government outlay, AUD
Scripts dispensed
—
prescriptions filled
PBS government benefit
PBS spending — three decades of growth
Government benefit paid to dispensing pharmacies. Source: pbs.gov.au statistics.
Run
python build_site_data.py to load PBS data
PBAC outcomes
Recommendation breakdown
All extracted PSDs, by latest decision per drug
Loading…
Source: extracted PBAC PSDs. Latest decision per drug; resubmissions counted within the drug record.
Activity
PSDs published per year
Volume of public summary documents issued by PBAC
Loads with PSD data
Counts only public summary documents indexed in this database. Each PSD = one PBAC consideration.
Government benefit by drug
Where the PBS dollars go
Top medicines by government benefit · click any drug to view its PBAC profile
Top 10 by spend
Highest government benefit
Loads with PBS drug-spend data
Government benefit (AUD) paid to dispensers in the latest reporting year.
Top 10 cost-per-script
Most expensive per dispensing
Minimum 50 scripts to filter low-volume noise
- —Loading…
Source: PBS drug-level statistics, latest financial year.
Therapeutic class
Where the spend concentrates
Top ATC drug classes by 2024 PBS government benefit
ATC level 2
Top 10 classes by spend
- —Run build_site_data.py to load ATC data
Government benefit (AUD) by Anatomical Therapeutic Chemical class.
PBAC pipeline
PSDs by therapy area
Volume of decisions assessed, latest decision per drug
Therapy areas extracted from PSD body text. Multi-area drugs counted once.
Cost effectiveness
ICERs and the path to listing
Incremental cost-effectiveness ratios extracted from PSD economic evaluations
ICER distribution
The $75k ceiling, in practice
Base-case ICERs across recommended drugs (AUD per QALY)
Loading ICER distribution…
Lybrand & Wonder (2020) found PBAC has historically not recommended drugs above ~$75,000 AUD/QALY at base case.
Persistence
Submissions to listing
How many PBAC attempts before a drug is recommended
Loading submission counts…
Counted from extracted PSD history. Lybrand & Wonder (2020) reported a mean of 1.70 submissions per recommended drug.
Therapy-area outcomes
Recommendation rate by therapy area
% of unique drugs recommended at the latest PBAC decision
Recommended share
% recommended, by therapy area
Includes "Recommended" and "Recommended with restriction" outcomes.
Resubmission rate
% needing more than one attempt
Of recommended drugs, how often the first submission wasn't enough
Among recommended drugs only. Therapy areas with <5 recommended drugs are excluded.
All decisions
Browse the full database
Click any row for the full PBAC profile · click column headers to sort
Loading…
Showing latest decision per drug
| Drug ↕ | Therapy area ↕ | Indication | PBAC outcome ↕ | Year ↕ | Submissions ↕ | ICER (AUD/QALY) ↕ |
|---|---|---|---|---|---|---|
| Run build_site_data.py to populate the decisions table | ||||||